New drug trial aims to slow devastating ALS nerve damage
NCT ID NCT06365216
Summary
This study is testing whether an investigational drug called NX210c can slow the progression of ALS (amyotrophic lateral sclerosis). It will involve about 80 adults with ALS who will receive either the drug or a placebo through intravenous infusions. The main goals are to see if the drug is safe and if it can reduce signs of nerve damage and help restore the protective barrier around the brain and spinal cord.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHRU De Nancy
Nancy, France, 54000, France
-
CHU de Lyon HCL
Bron, 69500, France
-
Centre Hospitalier Et Universitaire de Limoges
Limoges, 87042, France
-
Centre Hospitalier Regional Et Universitaire De Brest
Brest, France, 29200, France
-
Centre Hospitalier Regional Universitaire de Tours
Tours, 37044, France
-
Centre Hospitalier Universitaire De Bordeaux
Bordeaux, 33000, France
-
Centre Hospitalier Universitaire De Caen Normandie
Caen, France, 14033, France
-
Centre Hospitalier Universitaire d'Angers
Angers, 49100, France
-
Centre Hospitalier Universitaire de Clermont-Ferrand - Hôpital Gabriel Montpied
Clermont-Ferrand, 63003, France
-
Centre Hospitalier Universitaire de Lille
Lille, 59037, France
-
Centre Hospitalier Universitaire de Montpellier
Montpellier, 34295, France
-
Centre Hospitalier Universitaire de Nantes - Hôpital Nord Laennec
Nantes, 44093, France
-
Centre Hospitalier Universitaire de Nice
Nice, 06000, France
-
Centre Hospitalier Universitaire de Rennes
Rennes, 35000, France
-
Hôpital La Timone - APHM
Marseille, France, 13005, France
-
Hôpital de la Pitié Salpêtrière
Paris, 75013, France
Conditions
Explore the condition pages connected to this study.